Connect Biopharma Hldgs Analyst Ratings
Connect Biopharma Hldgs Analyst Ratings
While ratings are subjective and will change, the latest Connect Biopharma Hldgs (CNTB) rating was a reiterated with a price target of $0.00 to $5.00. The current price Connect Biopharma Hldgs (CNTB) is trading at is $0.76, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/13/2023 | 559.8% | Cantor Fitzgerald | → $5 | Reiterates | Overweight → Overweight |
| 02/08/2023 | 823.73% | SVB Leerink | $9 → $7 | Maintains | Outperform |
| 06/02/2022 | 559.8% | Cantor Fitzgerald | → $5 | Initiates Coverage On | → Overweight |
| 05/05/2022 | 97.94% | Piper Sandler | $25 → $1.5 | Downgrades | Overweight → Neutral |
| 05/04/2022 | 1087.65% | SVB Leerink | $22 → $9 | Maintains | Outperform |
| 01/06/2022 | 2803.14% | SVB Leerink | $32 → $22 | Maintains | Outperform |
| 07/02/2021 | 3462.95% | CICC | → $27 | Initiates Coverage On | → Outperform |
| 04/13/2021 | 3462.95% | Jefferies | → $27 | Initiates Coverage On | → Buy |
| 04/13/2021 | 4122.75% | SVB Leerink | → $32 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 09/13/2023 | 559.8% | 坎托·菲茨杰拉德 | → 5 美元 | 重申 | 超重 → 超重 |
| 02/08/2023 | 823.73% | SVB Leerink | 9 美元 → 7 美元 | 维护 | 跑赢大盘 |
| 06/02/2022 | 559.8% | 坎托·菲茨杰拉德 | → 5 美元 | 启动覆盖范围开启 | → 超重 |
| 05/05/2022 | 97.94% | 派珀·桑德勒 | 25 美元 → 1.5 美元 | 降级 | 超重 → 中性 |
| 05/04/2022 | 1087.65% | SVB Leerink | 22 美元 → 9 美元 | 维护 | 跑赢大盘 |
| 01/06/2022 | 2803.14% | SVB Leerink | 32 美元 → 22 美元 | 维护 | 跑赢大盘 |
| 07/02/2021 | 3462.95% | CICC | → 27 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 2021 年 4 月 13 日 | 3462.95% | 杰富瑞 | → 27 美元 | 启动覆盖范围开启 | → 购买 |
| 2021 年 4 月 13 日 | 4122.75% | SVB Leerink | → 32 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
What is the target price for Connect Biopharma Hldgs (CNTB)?
Connect Biopharma Hldgs（CNTB）的目标价格是多少？
The latest price target for Connect Biopharma Hldgs (NASDAQ: CNTB) was reported by Cantor Fitzgerald on September 13, 2023. The analyst firm set a price target for $5.00 expecting CNTB to rise to within 12 months (a possible 559.80% upside). 2 analyst firms have reported ratings in the last year.
坎托·菲茨杰拉德于2023年9月13日公布了Connect Biopharma Hldgs（纳斯达克股票代码：CNTB）的最新目标股价。该分析公司将目标股价定为5.00美元，预计CNTB将在12个月内上涨至59.80％（可能上涨559.80％）。去年，有2家分析公司公布了评级。
What is the most recent analyst rating for Connect Biopharma Hldgs (CNTB)?
Connect Biopharma Hldgs（CNTB）的最新分析师评级是多少？
The latest analyst rating for Connect Biopharma Hldgs (NASDAQ: CNTB) was provided by Cantor Fitzgerald, and Connect Biopharma Hldgs reiterated their overweight rating.
Connect Biopharma Hldgs（纳斯达克股票代码：CNTB）的最新分析师评级由坎托·菲茨杰拉德提供，Connect Biopharma Hldgs重申了其增持评级。
When is the next analyst rating going to be posted or updated for Connect Biopharma Hldgs (CNTB)?
Connect Biopharma Hldgs（CNTB）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Connect Biopharma Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Connect Biopharma Hldgs was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Connect Biopharma Hldgs的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Connect Biopharma Hldgs的最后一次评级是在2023年9月13日提交的，因此你应该预计下一个评级将在2024年9月13日左右公布。
Is the Analyst Rating Connect Biopharma Hldgs (CNTB) correct?
分析师评级Connect Biopharma Hldgs（CNTB）是否正确？
While ratings are subjective and will change, the latest Connect Biopharma Hldgs (CNTB) rating was a reiterated with a price target of $0.00 to $5.00. The current price Connect Biopharma Hldgs (CNTB) is trading at is $0.76, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的Connect Biopharma Hldgs（CNTB）评级，目标股价为0.00美元至5.00美元。Connect Biopharma Hldgs（CNTB）目前的交易价格为0.76美元，在分析师的预测区间内。
译文内容由第三方软件翻译。
